Table 1.

Comparison of Demographic and Clinical Characteristics of Patients with Uterine Sarcoma vs Fibroids

	Uterine Sarcoma	Uterine Fibroids	P-value
Mean age in years ± SD	62.1 ± 10.1	46.5 ± 6.6	<.0001
Menopausal status, n (%)
Premenopausal	12 (18.2)	59 (90.8)	<.0001
Postmenopausal	54 (81.8)	6 (9.2)
Median gravidity, n (range)	2 (0 to 8)	2 (0 to 8)	.74
Median parity, n (range)	2 (0 to 7)	2 (0 to 5)	.17
History of previous nonuterine malignancy, n (%)	11 (16.7)	3 (4.6)	.02
Patient symptoms, n (%)
Pain or pressure	29 (43.9)	34 (51.5)	.38
Heavy menstrual bleeding	9 (13.6)	45 (68.2)	<.0001
Postmenopausal bleeding	36 (54.6)	2 (3.0)	<.0001
Ultrasound characteristics
Number of masses, n (%)
1	27 (56.3)	12 (18.5)
2	9 (18.8)	4 (6.2)
≥ 3	12 (25.0)	49 (75.4)	<.0001
Position of mass within uterus, n (%)
Submucosal	7 (19.4)	13 (28.3)	.36
Subserosal	25 (69.4)	16 (34.8)	<.0001
Intramural	4 (11.1)	17 (37.0)	.01
Mean diameter of largest mass, cm ± SD	9.6 ± 5.6	8.5 ± 3.9	.40
Documented concern about rapid growth, n (%)	11 (16 .7)	3 (4.6)	.02

n = 66. Data are from the medical records of The Ottawa Hospital, Ontario, Canada, April 1, 2007 to March 31, 2014.